SPP1 polymorphisms associated with HBV clearance and HCC occurrence

International Journal of Epidemiology

Volumn 36, Issue 5, 2007, Pages 1001-1008

  Shin, Hyoung Doo ^a   Park, Byung Lae ^a   Cheong, Hyun Sub ^a   Yoon, Jung Hwan ^b   Kim, Yoon Jun ^b   Lee, Hyo Suk ^b  

^a SNP Genetics Inc   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Haplotype; HBV; HCC; Single nucleotide polymorphism; SPP1

Indexed keywords

OSTEOPONTIN; PHOSPHOPROTEIN;

GENE; GENOTYPE; HEPATITIS; POLYMORPHISM; PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHROMOSOME MAPPING; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

HEPATITIS B VIRUS;

EID: 35548972515     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym093     Document Type: Article

References (45)

1. Kane MA. [World-wide epidemiology of hepatitis B]. Soz Praventivmed 1998;43 (Suppl 1):S24-6,S98-100.
2. PurCell RH. The discovery of the hepatitist viruses. Gastroentorology 1993;104:955-63.
3. Blumberg BS. Hepatitis B virus and the control of hepatocellular carcinoma. IARC Sci Publ 1984;63:243-61.
4. Huh K, Choi SY, Whang YS, Lee DS. Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma. J Korean Med Sci 1998;13:306-10.
5. Merican I, Guan R, Amarapuka D et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000;15 1356-61.
6. Lin TM, Chen CJ, Wu MM et al. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989;9:737-41.
7. Yu MW, Chang HC, Liaw YF et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000;92:1159-64.
8. Coursaget P, Yvonnet B, Chotard J et al. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987;22:1-5.
9. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-74.
10. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987;92:1844-50.
11. Lok AS, Lai CL, Wu PC, Wong VC, Yeoh EK, Lin HJ. Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol 1987; 126:492-99.
12. Cacciola I, Cerenzia G, Pollicino T et al. Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. J Hepatol 2002;36:426-32.
13. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332:1065-69.
14. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
15. Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986;83:8819-23.
16. Ashkar S, Weber GF, Panoutsakopoulou V et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000;287:860-64.
17. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (sppl). J Clin Invest 1998;101:1468-78.
18. Singh K, DeVouge MW, Mukherjee BB. Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J Biol Chem 1990;265:18696-701.
19. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 2002;52 19-24.
20. Reinholz MM, Iturria SJ, Ingle JN, Roche PC. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: Analysis by real-time quantitative PCR. Breast Cancer Res Treat 2002;74:255-69.
21. Urquidi V, Sloan D, Kawai K et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin Cancer Res 2002;8:61-74.
22. Tozawa K, Yamada Y, Kawai N, Okamura T, Ueda K, Kohri K. Osteopontin expression in prostate cancer and benign prostatic hyperplasia. Urol Int 1999;62:155-58.
23. Kim JH, Skates SJ, Uede T et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer. Jama 2002;287 1671-79.
24. Ding Q, Stewart J Jr, Prince CW et al. Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res 2002;62:5336-43.
25. Weber GF, Ashkar S. Molecular mechanisms.of tumor dissemination in primary ahd metastatic brain cancers. Brain Res Bull 2000;53 421-24.
26. Zhang J, Takahashi K; Takahashi F et al. Differential osteopontin expression in lung cancer. Cancer Lett 2001;171:215-22.
27. Ye QH, Qin LX, Forgues M et al. Pridicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003;9:416-23.
28. Iwasaki H, Shinohara Y, Ezura Y et al. Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals. J Hum Genet 2001;46 544-46.
29. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. Buropean Association for the Study of the Liver. J Hepatol 2001;35:421-30.
30. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143-49.
31. Barrett JC, Fry B, Mallet J, Daly MJ. Haploview: Analysis and visualization of LD and hapldtype maps. Bioinformatics 2005;21 263-65.
32. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 200l;68 978-89.
33. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004;74:765-69.
34. Bae SH, Yoon SK, Jang JW et al. Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea. J Korean Med Sci 2005;20:816-20.
35. Odgerel Z, Nho KB, Moon JY et al. Complete genome sequence and phylogenetic analysis of hepatitis B virus (HBV) isolates from patients with chronic HBV infection in Korea. J Med Virol 2003;71:499-503.
36. Song BC, Cui XJ, Kim H. Hepatitis B virus genotypes in Korea: An endemic area of hepatitis B virus infection. Intervirology 2005;48 133-37.
37. Song BC, Kim H, Kim SH, Cha CY, Kook YH, Kim W. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J Med Virol 2005;75:13-19.
38. Yoo BC, Park JW, Kim HJ, Lee DH, Cha YJ, Park SM. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol 2003; 38:98-103.
39. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med1981;94:744-48.
40. Lieberman HM, LaBrecque DF, Kew MC, Hadziyannis SJ, Shafritz DA. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: Comparison to HBeAg/anti-HBe: status in HBsAg carriers. Hepatology 1983;3:285-91.
41. Realdi G, Alberti A, Rugge M et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-99.
42. Naito M, Matsui A. Inao M et al. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C. J Gastroenterol 2005;40:381-88.
43. Denhardt DT, Giachelli CM, Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 2001; 41:723-49.
44. Wai PY, Kuo PC. The role of Osteopontin in tumor metastasis. J Surg Res 2004;121:228-41.
45. Chiocchetti A, Iridelicato, M, Bensi T ee al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 2004; 103:1376-82.